Molecular subtypes, stem cells and heterogeneity: Implications for personalised therapy in glioma.

Ichiro Nakano, Harley I. Kornblum, Methods for analysis of brain tumor stem cell and neural stem cell self-renewal. Methods of Molecular Biology. ,vol. 568, pp. 37- 56 ,(2009) , 10.1007/978-1-59745-280-9_4

Norihiko Saito, Jun Fu, Siyuan Zheng, Jun Yao, Shuzhen Wang, Diane D. Liu, Ying Yuan, Erik P. Sulman, Frederick F. Lang, Howard Colman, Roel G. Verhaak, W. K. Alfred Yung, Dimpy Koul, A High Notch Pathway Activation Predicts Response to γ Secretase Inhibitors in Proneural Subtype of Glioma Tumor-Initiating Cells STEM CELLS. ,vol. 32, pp. 301- 312 ,(2014) , 10.1002/STEM.1528

David N. Louis, WHO classification of tumours of the central nervous system International Agency for Research on Cancer. ,(2007)

Percival Bailey, Harvey Cushing, A classification of the tumors of the glioma group on a histogenetic basis with a correlated study of prognosis ,(1970)

M. Chekenya, G. J. Pilkington, NG2 precursor cells in neoplasia: functional, histogenesis and therapeutic implications for malignant brain tumours. Journal of Neurocytology. ,vol. 31, pp. 507- 521 ,(2002) , 10.1023/A:1025795715377

Guido Reifenberger, Ruthild G. Weber, Vera Riehmer, Kerstin Kaulich, Edith Willscher, Henry Wirth, Jens Gietzelt, Bettina Hentschel, Manfred Westphal, Matthias Simon, Gabriele Schackert, Johannes Schramm, Jakob Matschke, Michael C. Sabel, Dorothee Gramatzki, Jörg Felsberg, Christian Hartmann, Joachim P. Steinbach, Uwe Schlegel, Wolfgang Wick, Bernhard Radlwimmer, Torsten Pietsch, Jörg C. Tonn, Andreas von Deimling, Hans Binder, Michael Weller, Markus Loeffler, , Molecular characterization of long-term survivors of glioblastoma using genome- and transcriptome-wide profiling. International Journal of Cancer. ,vol. 135, pp. 1822- 1831 ,(2014) , 10.1002/IJC.28836

Nicola Montano, Tonia Cenci, Maurizio Martini, Quintino Giorgio D’Alessandris, Federica Pelacchi, Lucia Ricci-Vitiani, Giulio Maira, Ruggero De Maria, Luigi Maria Larocca, Roberto Pallini, Expression of EGFRvIII in glioblastoma: prognostic significance revisited. Neoplasia. ,vol. 13, pp. 1113- 1121 ,(2011) , 10.1593/NEO.111338

Jennifer R. Molina, Yuho Hayashi, Clifton Stephens, Maria-Magdalena Georgescu, Invasive glioblastoma cells acquire stemness and increased Akt activation. Neoplasia. ,vol. 12, pp. 453- 463 ,(2010) , 10.1593/NEO.10126

Yuchen Jiao, Patrick J. Killela, Zachary J. Reitman, B. Ahmed Rasheed, Christopher M. Heaphy, Roeland F. de Wilde, Fausto J. Rodriguez, Sergio Rosemberg, Sueli Mieko Oba-Shinjo, Suely Kazue Nagahashi Marie, Chetan Bettegowda, Nishant Agrawal, Eric Lipp, Christopher J. Pirozzi, Giselle Y. Lopez, Yiping He, Henry S. Friedman, Allan H. Friedman, Gregory J. Riggins, Matthias Holdhoff, Peter Burger, Roger E. McLendon, Darell D. Bigner, Bert Vogelstein, Alan K. Meeker, Kenneth W. Kinzler, Nickolas Papadopoulos, Luis A. Diaz, Hai Yan, Frequent ATRX, CIC, FUBP1 and IDH1 mutations refine the classification of malignant gliomas. Oncotarget. ,vol. 3, pp. 709- 722 ,(2012) , 10.18632/ONCOTARGET.588

Giuseppe Minniti, Claudia Scaringi, Antonella Arcella, Gaetano Lanzetta, Domenica Di Stefano, Stefania Scarpino, Alessandro Bozzao, Andrea Pace, Veronica Villani, Maurizio Salvati, Vincenzo Esposito, Felice Giangaspero, Riccardo Maurizi Enrici, IDH1 mutation and MGMT methylation status predict survival in patients with anaplastic astrocytoma treated with temozolomide-based chemoradiotherapy Journal of Neuro-oncology. ,vol. 118, pp. 377- 383 ,(2014) , 10.1007/S11060-014-1443-0